Literature DB >> 20039127

Bone mineral density in patients on maintenance dialysis.

Csaba Ambrus1, Adrienn Marton, Zsofia Klara Nemeth, Istvan Mucsi.   

Abstract

Disorders of bone and mineral metabolism affect almost all patients with advanced chronic kidney disease (CKD). High prevalence of decreased bone mineral density has been reported in this population; however, the role and diagnostic utility of bone density measurements are not well established. The incidence of bone fractures is high in patients with ESRD, but the association between fractures and bone density is not obvious. A recent meta-analysis suggested that decreased density at the radius might be associated with higher overall fracture risk. Changes in bone mineral density reflect several underlying pathological processes, such as vitamin D deficiency, estrogen deficiency and changes in bone turnover. The response of bone to these factors and processes is not uniform: it can vary in different compartments of the same bone or in different bones of the skeleton. Therefore, it is important to differentiate between the various types of bone. This may be possible by proper selection of the measurement site or using methods such as quantitative bone computed tomography. Previous studies used different methods and measured bone mineral density at diverse sites of the skeleton, which makes the comparison of their results very difficult. The association between changes in bone mineral metabolism and cardiovascular mortality is well known in ESRD patients. Studies also suggest that low bone density itself might be an indicator for high risk of cardiovascular events and poor overall outcome in this population. Some of the risk factors of low bone mineral density, such as vitamin D or estrogen deficiency, are potentially modifiable. Further studies are needed to elucidate if interventions modifying these risk factors will have an impact on clinical outcomes. In this review, we discuss the options for and problems of assessment of bone density and summarize the literature about factors associated with low bone density and its link to clinical outcomes in patients on maintenance dialysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20039127     DOI: 10.1007/s11255-009-9666-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  119 in total

Review 1.  Quantitative ultrasound in postmenopausal osteoporosis.

Authors:  C Roux; M Dougados
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

2.  Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults.

Authors:  Heike A Bischoff-Ferrari; Thomas Dietrich; E John Orav; Bess Dawson-Hughes
Journal:  Am J Med       Date:  2004-05-01       Impact factor: 4.965

Review 3.  Osteoporosis in chronic kidney disease.

Authors:  John Cunningham; Stuart M Sprague; Jorge Cannata-Andia; Maria Coco; Martine Cohen-Solal; Lorraine Fitzpatrick; David Goltzmann; Marie-Helene Lafage-Proust; Mary Leonard; Susan Ott; Mariano Rodriguez; Catherine Stehman-Breen; Paula Stern; Jose Weisinger
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

Review 4.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

5.  Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.

Authors:  A Gerakis; A J Hutchison; T Apostolou; A J Freemont; A Billis
Journal:  Nephrol Dial Transplant       Date:  1996-12       Impact factor: 5.992

6.  Risk factors for hip fracture among patients with end-stage renal disease.

Authors:  C O Stehman-Breen; D J Sherrard; A M Alem; D L Gillen; S R Heckbert; C S Wong; A Ball; N S Weiss
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

7.  Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis.

Authors:  C R Russo; G Taccetti; P Caneva; A Mannarino; P Maranghi; M Ricca
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

8.  Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.

Authors:  Fumiko Kojima; Keiko Uchida; Tetsuya Ogawa; Yoshiko Tanaka; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2008-09-13       Impact factor: 2.370

9.  Mineralized bone loss at different sites in dialysis patients: implications for prevention.

Authors:  H C Schober; Z H Han; A J Foldes; M S Shih; D S Rao; R Balena; A M Parfitt
Journal:  J Am Soc Nephrol       Date:  1998-07       Impact factor: 10.121

10.  Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease.

Authors:  A J Hutchison; R W Whitehouse; H F Boulton; J E Adams; E B Mawer; T J Freemont; R Gokal
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

View more
  9 in total

1.  Association between high-molecular-weight adiponectin and bone mineral density in hemodialysis patients.

Authors:  Nobuyuki Amemiya; Shigeru Otsubo; Yuko Iwasa; Takako Onuki; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-11-14       Impact factor: 2.801

2.  Calcification of the thoracic aorta determined by three-dimensional computed tomography predicts cardiovascular complications in patients undergoing hemodialysis.

Authors:  Nozomu Kamiura; Kiyoko Yamamoto; Shioko Okada; Makoto Sakai; Akira Fujimori
Journal:  Int Urol Nephrol       Date:  2013-12-07       Impact factor: 2.370

3.  Forearm bone mass predicts mortality in chronic hemodialysis patients.

Authors:  Lidija Orlic; Ivana Mikolasevic; Zeljka Crncevic-Orlic; Ivan Jakopcic; Josipa Josipovic; Drasko Pavlovic
Journal:  J Bone Miner Metab       Date:  2016-07-27       Impact factor: 2.626

4.  Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis.

Authors:  Annelie Bergman; Abdul Rashid Qureshi; Mathias Haarhaus; Bengt Lindholm; Peter Barany; Olof Heimburger; Peter Stenvinkel; Björn Anderstam
Journal:  J Nephrol       Date:  2016-03-18       Impact factor: 3.902

Review 5.  Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient.

Authors:  James Goya Heaf
Journal:  Perit Dial Int       Date:  2015-11       Impact factor: 1.756

6.  Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients.

Authors:  Chih-Hsien Wang; Jen-Pi Tsai; Yu-Hsien Lai; Yu-Li Lin; Chiu-Huang Kuo; Bang-Gee Hsu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2016-05-28

7.  Bone density of the femoral neck in patients on maintenance dialysis.

Authors:  Kazushige Nakanishi; Kanji Shishido; Chiaki Kumata; Kae Ito; Yutaka Nakashima; Mikio Wakasa
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

8.  Increased Serum Leptin Level Predicts Bone Mineral Density in Hemodialysis Patients.

Authors:  Chih-Hsien Wang; Yu-Hsien Lai; Yu-Li Lin; Chiu-Huang Kuo; Ru-Jiang Syu; Ming-Chun Chen; Bang-Gee Hsu
Journal:  Int J Endocrinol       Date:  2020-06-03       Impact factor: 3.257

9.  Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patients.

Authors:  Shuo Yang; Qingyu Niu; Liangying Gan; Xiaobo Zhang; Lingxue Tu; Li Zuo
Journal:  Hemodial Int       Date:  2020-06-10       Impact factor: 1.812

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.